Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT07449208
Conditions
Esophageal Malignant Neoplasm Primary
Anastomotic Leak
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Esophagectomy
Brief summary:
Conditions
Esophageal Malignant Neoplasm Primary
Anastomotic Leak
Study ID
NCT07449208
Start date
Feb 25, 2026
Status verified date
Feb, 2026
Completion date
Feb 25, 2029
Anticipated
Primary completion date
Feb 25, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Arms
Participants Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
Interventions
Esophagectomy
Primary outcome measure
Central contacts
Locations
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Recruiting
Basking Ridge, New Jersey, United States, 07920
Contacts
Daniela Molena, MD
212-639-3870Memorial Sloan Kettering Monmouth (All Protocol Activities)
Recruiting
Middletown, New Jersey, United States, 07748
Contacts
Daniela Molena, MD
212-639-3870Memorial Sloan Kettering Bergen (All Protocol Activities)
Recruiting
Montvale, New Jersey, United States, 07645
Contacts
Daniela Molena, MD
212-639-3870Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Recruiting
Commack, New York, United States, 11725
Contacts
Daniela Molena, MD
212-639-3870Memorial Sloan Kettering Westchester (All protocol activities)
Recruiting
Harrison, New York, United States, 10604
Contacts
Daniela Molena, MD
212-639-3870Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Recruiting
New York, New York, United States, 10065
Contacts
Daniela Molena, MD
212-639-3870Memorial Sloan Kettering Nassau (All Protocol Activities)
Recruiting
Rockville Centre, New York, United States, 11553
Contacts
Daniela Molena, MD
212-639-3870Sponsor
Memorial Sloan Kettering Cancer Center
Last update posted
Mar 4, 2026
Last verified
Feb, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-03-04.